Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventionsCyril Willemart, Tom Vanden Berghe, Jorien De Loor et al.|Cell Death and Differentiation|2025Cited by 8
Nanopore sequencing enables tissue-of-origin and pathogen detection in plasma cell-free DNA from critically ill patientsCyril Willemart, Tom Vanden Berghe, Mojca Stražišar et al.|Cell Death Discovery|2025Cited by 0